JP5080457B2 - 液体中に短寿命の物理的特性を有するガスを溶解させることによるコントラスト剤の調製方法 - Google Patents
液体中に短寿命の物理的特性を有するガスを溶解させることによるコントラスト剤の調製方法 Download PDFInfo
- Publication number
- JP5080457B2 JP5080457B2 JP2008515120A JP2008515120A JP5080457B2 JP 5080457 B2 JP5080457 B2 JP 5080457B2 JP 2008515120 A JP2008515120 A JP 2008515120A JP 2008515120 A JP2008515120 A JP 2008515120A JP 5080457 B2 JP5080457 B2 JP 5080457B2
- Authority
- JP
- Japan
- Prior art keywords
- gas
- liquid
- membrane
- short
- hyperpolarized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007788 liquid Substances 0.000 title claims description 77
- 238000000034 method Methods 0.000 title claims description 57
- 230000000704 physical effect Effects 0.000 title claims description 27
- 239000002872 contrast media Substances 0.000 title claims description 12
- 238000002360 preparation method Methods 0.000 title claims description 3
- 239000012528 membrane Substances 0.000 claims description 60
- 229910052724 xenon Inorganic materials 0.000 claims description 43
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims description 43
- 239000012510 hollow fiber Substances 0.000 claims description 22
- -1 polypropylene Polymers 0.000 claims description 8
- 229920000098 polyolefin Polymers 0.000 claims description 7
- 230000002209 hydrophobic effect Effects 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 229920000306 polymethylpentene Polymers 0.000 claims description 2
- 239000011116 polymethylpentene Substances 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 239000004447 silicone coating Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims 2
- 239000007789 gas Substances 0.000 description 98
- 239000000243 solution Substances 0.000 description 21
- 230000005291 magnetic effect Effects 0.000 description 15
- 238000005481 NMR spectroscopy Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 5
- 230000028161 membrane depolarization Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000002285 radioactive effect Effects 0.000 description 5
- 238000003325 tomography Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 3
- 229910052756 noble gas Inorganic materials 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 150000002835 noble gases Chemical class 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 238000002600 positron emission tomography Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241001267704 Oxyphanes Species 0.000 description 1
- UQVKZNNCIHJZLS-UHFFFAOYSA-N PhIP Chemical compound C1=C2N(C)C(N)=NC2=NC=C1C1=CC=CC=C1 UQVKZNNCIHJZLS-UHFFFAOYSA-N 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003633 blood substitute Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000003058 plasma substitute Substances 0.000 description 1
- 229920000110 poly(aryl ether sulfone) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/20—Mixing gases with liquids
- B01F23/23—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids
- B01F23/231—Mixing gases with liquids by introducing gases into liquid media, e.g. for producing aerated liquids by bubbling
- B01F23/23105—Arrangement or manipulation of the gas bubbling devices
- B01F23/2312—Diffusers
- B01F23/23124—Diffusers consisting of flexible porous or perforated material, e.g. fabric
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005026604.5 | 2005-06-09 | ||
| DE102005026604A DE102005026604A1 (de) | 2005-06-09 | 2005-06-09 | Verfahren zum Lösen von Gasen mit kurzlebigen physikalischen Eigenschaften in einer Flüssigkeit |
| PCT/EP2006/005349 WO2006131292A2 (de) | 2005-06-09 | 2006-06-06 | Verfahren zum lösen von gasen mit kurzlebigen physikalischen eigenschaften in einer flüssigkeit |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009523116A JP2009523116A (ja) | 2009-06-18 |
| JP2009523116A5 JP2009523116A5 (enExample) | 2012-04-19 |
| JP5080457B2 true JP5080457B2 (ja) | 2012-11-21 |
Family
ID=37398693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008515120A Expired - Fee Related JP5080457B2 (ja) | 2005-06-09 | 2006-06-06 | 液体中に短寿命の物理的特性を有するガスを溶解させることによるコントラスト剤の調製方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20080199401A1 (enExample) |
| EP (1) | EP1901782B1 (enExample) |
| JP (1) | JP5080457B2 (enExample) |
| DE (1) | DE102005026604A1 (enExample) |
| ES (1) | ES2393113T3 (enExample) |
| WO (1) | WO2006131292A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0804422D0 (en) * | 2008-03-10 | 2008-04-16 | Univ Southampton | An agent for transporting nuclear spin order and for magnetic resonance imaging |
| DE102013013197A1 (de) * | 2013-08-09 | 2015-02-12 | Bundesrepublik Deutschland, vertreten durch das Bundesministerium für Wirtschaft und Arbeit, dieses vertreten durch den Präsidenten der Physikalisch-Technischen Bundesanstalt Braunschweig und Berlin | Verfahren und Vorrichtung zum kryogenfreien Aufkonzentrieren eines hyperpolarisierten Gases in einem kontinuierlich fließenden Gasstrom und Verwendung |
| FR3030770B1 (fr) | 2014-12-19 | 2019-08-30 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Cellule de mesure de rmn et ensemble de mesure de rmn |
| CN119086618B (zh) * | 2023-09-06 | 2025-10-03 | 中国科学院精密测量科学与技术创新研究院 | 用于超极化129Xe磁共振分子探针流动采样的装置及方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2833493C2 (de) * | 1978-07-31 | 1989-10-12 | Akzo Gmbh, 5600 Wuppertal | Hohlfäden |
| US5357959A (en) * | 1993-04-16 | 1994-10-25 | Praxair Technology, Inc. | Altered dipole moment magnetic resonance imaging method |
| US5545396A (en) * | 1994-04-08 | 1996-08-13 | The Research Foundation Of State University Of New York | Magnetic resonance imaging using hyperpolarized noble gases |
| JP2001503646A (ja) * | 1996-03-29 | 2001-03-21 | ローレンス バークレー ナショナル ラボラトリィ | 過分極化希ガス存在下でのnmrまたはmriの増強 |
| ATE252916T1 (de) * | 1997-08-12 | 2003-11-15 | Bracco Research Sa | Verabreichbare formulierugen und ihre anwendung in mri |
| JPH11179167A (ja) * | 1997-12-25 | 1999-07-06 | Nitto Denko Corp | スパイラル型膜モジュール |
| JP3352411B2 (ja) * | 1998-03-05 | 2002-12-03 | 株式会社東芝 | 制御システム、電力系統保護制御システムおよびプログラムを記憶した記憶媒体 |
| JP2002507438A (ja) * | 1998-03-18 | 2002-03-12 | メディ−フィジックス・インコーポレイテッド | 溶解化した極性化129Xeを用いる肺および心臓脈管構造の映像化および血流を上昇するMR方法 |
| US6284222B1 (en) * | 1998-11-03 | 2001-09-04 | Medi--Physics, Inc. | Hyperpolarized helium-3 microbubble gas entrapment methods |
| CA2401308A1 (en) * | 2000-03-13 | 2001-09-20 | Klaus D. Hagspiel | Diagnostic procedures using direct injection of gaseous hyperpolarized 129xe and associated systems and products |
| US6775568B2 (en) * | 2000-04-12 | 2004-08-10 | University Of Virginia Patent Foundation | Exchange-based NMR imaging and spectroscopy of hyperpolarized xenon-129 |
| US6696040B2 (en) * | 2000-07-13 | 2004-02-24 | Medi-Physics, Inc. | Diagnostic procedures using 129Xe spectroscopy characteristic chemical shift to detect pathology in vivo |
| AU2002258961A1 (en) * | 2001-04-24 | 2002-11-05 | Medi-Physics, Inc. | Methods and devices for moisturizing hyperpolarized noble gases and pharmaceutical products thereof |
-
2005
- 2005-06-09 DE DE102005026604A patent/DE102005026604A1/de not_active Withdrawn
-
2006
- 2006-06-06 WO PCT/EP2006/005349 patent/WO2006131292A2/de not_active Ceased
- 2006-06-06 EP EP06754128A patent/EP1901782B1/de not_active Not-in-force
- 2006-06-06 US US11/916,662 patent/US20080199401A1/en not_active Abandoned
- 2006-06-06 JP JP2008515120A patent/JP5080457B2/ja not_active Expired - Fee Related
- 2006-06-06 ES ES06754128T patent/ES2393113T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006131292A3 (de) | 2007-02-01 |
| WO2006131292A2 (de) | 2006-12-14 |
| DE102005026604A1 (de) | 2006-12-14 |
| US20080199401A1 (en) | 2008-08-21 |
| EP1901782A2 (de) | 2008-03-26 |
| EP1901782B1 (de) | 2012-08-15 |
| JP2009523116A (ja) | 2009-06-18 |
| ES2393113T3 (es) | 2012-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Berthault et al. | Biosensing using laser-polarized xenon NMR/MRI | |
| CN1429086A (zh) | 使用气态超极化129Xe的直接注射的诊断步骤以及相关系统和产品 | |
| JP2002528520A (ja) | 過分極ヘリウム‐3微泡取り込み方法 | |
| US20050030026A1 (en) | Enhancement of NMR and MRI in the presence of hyperpolarized noble gases | |
| CA2344671C (en) | Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers | |
| US20220161217A1 (en) | Systems, methods, and devices for production of gas-filled microbubbles | |
| Möller et al. | Magnetic resonance angiography with hyperpolarized 129Xe dissolved in a lipid emulsion | |
| CN1093893A (zh) | 交变偶极矩磁共振成像方法 | |
| JP2002507438A (ja) | 溶解化した極性化129Xeを用いる肺および心臓脈管構造の映像化および血流を上昇するMR方法 | |
| Cleveland et al. | In vivo MR imaging of pulmonary perfusion and gas exchange in rats via continuous extracorporeal infusion of hyperpolarized 129Xe | |
| Freeman et al. | Enabling hyperpolarized 129Xe MR spectroscopy and imaging of pulmonary gas transfer to the red blood cells in transgenic mice expressing human hemoglobin | |
| JP5080457B2 (ja) | 液体中に短寿命の物理的特性を有するガスを溶解させることによるコントラスト剤の調製方法 | |
| CN101878044A (zh) | 用于基于体磁化率效应的cest mri的非球形对比剂 | |
| CN1224502A (zh) | 利用超极化惰性气体对于核磁共振和磁共振成象质量的提高 | |
| Amor et al. | Magnetic resonance imaging of dissolved hyperpolarized 129Xe using a membrane-based continuous flow system | |
| Ożóg et al. | Monitoring photodynamic oxygen consumption by endogenous oxygen contrast MRI | |
| JP2009523116A5 (enExample) | ||
| Ceillier | Instrumental developments for dissolution dynamic nuclear polarization: generating, transferring and transporting hyperpolarization | |
| CROSS et al. | Effects of dilution and oxygenation on T1 of hyperpolarized 129Xe in perfluorocarbon emulsions | |
| US20140350382A1 (en) | Apparatus and method for administering contrast medium during magnetic resonance tomography, magnetic resonance tomography system and use of the apparatus | |
| Zhong | In vivo MR imaging and spectroscopic study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090413 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20101227 Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20101228 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111208 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20120305 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120405 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120705 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120822 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120830 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150907 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |